Zilixir Biotech
Zilixir Biotech provides AI-driven protein design and structure prediction to accelerate drug discovery and life sciences research. Their SWORD™ protein design technology integrates structure prediction, binding-pocket modelling, novel drug-scaffold generation, activity prediction, and ADME/T forecasting. The company operates as a B2B computational protein design and synthetic biology platform serving biotech and pharmaceutical R&D teams. Zilixir’s platform complements experimental workflows and in silico screening to help prioritize candidates for downstream development.
Zilixir Biotech
Zilixir Biotech provides AI-driven protein design and structure prediction to accelerate drug discovery and life sciences research. Their SWORD™ protein design technology integrates structure prediction, binding-pocket modelling, novel drug-scaffold generation, activity prediction, and ADME/T forecasting. The company operates as a B2B computational protein design and synthetic biology platform serving biotech and pharmaceutical R&D teams. Zilixir’s platform complements experimental workflows and in silico screening to help prioritize candidates for downstream development.